- Teva Pharmaceutical Industries (TEVA -1.9%) launches a generic equivalent of the insomnia drug Lunesta (eszopiclone) in the U.S.
- Sunovion Pharmaceuticals sells the branded product. Domestic sales are ~$850M.
Teva debuts insomnia drug
Recommended For You
More Trending News
About TEVA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| TEVA | - | - |
| Teva Pharmaceutical Industries Limited | ||